HOULIHAN LOKEY, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Houlihan Lokey, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2014 to Q3 2024.
  • Houlihan Lokey, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 68.4M shares, a 0.82% increase year-over-year.
  • Houlihan Lokey, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 68.2M shares, a 0.85% increase from 2022.
  • Houlihan Lokey, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 67.6M shares, a 0.99% decline from 2021.
  • Houlihan Lokey, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 68.3M shares, a 0.6% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 68.4M +555K +0.82% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 68.5M +501K +0.74% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 68.2M +573K +0.85% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-21
Q4 2023 67.9M -1.84M -2.64% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-08
Q3 2023 67.9M -1.93M -2.77% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 68M -828K -1.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 67.6M -673K -0.99% Jan 1, 2023 Mar 31, 2023 10-K 2024-05-21
Q4 2022 69.7M +1.45M +2.12% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 69.8M +1.23M +1.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 68.8M +110K +0.16% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 68.3M -412K -0.6% Jan 1, 2022 Mar 31, 2022 10-K 2024-05-21
Q4 2021 68.3M -1.08M -1.55% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q3 2021 68.6M -1.05M -1.51% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 68.7M +1.92M +2.87% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 68.7M +2.95M +4.48% Jan 1, 2021 Mar 31, 2021 10-K 2023-05-25
Q4 2020 69.4M +3.75M +5.71% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-08
Q3 2020 69.6M +3.53M +5.34% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 66.8M +1.18M +1.79% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 65.7M -121K -0.18% Jan 1, 2020 Mar 31, 2020 10-K 2022-05-27
Q4 2019 65.6M -151K -0.23% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 66.1M +40.3K +0.06% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 65.6M -533K -0.81% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 65.8M -478K -0.72% Jan 1, 2019 Mar 31, 2019 10-K 2021-05-21
Q4 2018 65.8M -364K -0.55% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 66M -862K -1.29% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 66.2M -216K -0.33% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 66.3M -255K -0.38% Jan 1, 2018 Mar 31, 2018 10-K 2020-05-15
Q4 2017 66.1M -569K -0.85% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-05
Q3 2017 66.9M +91.2K +0.14% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 66.4M +24.7K +0.04% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 66.6M +3.1M +4.89% Jan 1, 2017 Mar 31, 2017 10-K 2019-05-24
Q4 2016 66.7M +1.29M +1.97% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-07
Q3 2016 66.8M +4.12M +6.57% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 66.3M +5.88M +9.73% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 63.5M Jan 1, 2016 Mar 31, 2016 10-K 2018-05-25
Q4 2015 65.4M +5.09M +8.44% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-06
Q3 2015 62.7M +2.35M +3.89% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 60.5M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q4 2014 60.3M Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-11
Q3 2014 60.4M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.